The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype
U. J. Kozlowska, A. Klimczak, K. Wiatr, M. Figiel
This study shows DMT and psilocin reduce microglial inflammatory markers and enhance neuroprotective signaling, suggesting their potential as therapies for neurological disorders involving microglial inflammation.
bioRxiv · Mar 7, 2021 · PreprintCell Biology